KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Acquisitions (2025)

Historic Acquisitions for Royalty Pharma (RPRX) over the last 1 years, with Q3 2025 value amounting to $226000.0.

  • Royalty Pharma's Acquisitions changed N/A to $226000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $226000.0, marking a year-over-year change of. This contributed to the annual value of $74.4 million for FY2025, which is N/A changed from last year.
  • Per Royalty Pharma's latest filing, its Acquisitions stood at $226000.0 for Q3 2025.
  • In the past 5 years, Royalty Pharma's Acquisitions ranged from a high of $226000.0 in Q3 2025 and a low of $226000.0 during Q3 2025